Peter A Thompson Insider Trading $THOR Synthorx, Inc.
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).
Peter A Thompson in Synthorx, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 0 shares
Latest Transaction: Jan 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A Thompson in Synthorx, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | D | 12.40 | 15,335 | 190,154 | 0 | |
| Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | D | 11.00 | 30,000 | 330,000 | 0 | |
| Jan 24 2020 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Sell | U | 68.00 | 5,316,355 | 361,512,140 | 0 | 5.3 M to 0 (-100.00 %) |
| Jun 10 2019 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | A | 12.40 | 15,335 | 190,154 | 15,335 | |
| Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 6,333,206 | 0 | 0 | |
| Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Buy | P | 11.00 | 1,363,636 | 14,999,996 | 5,316,355 | 4 M to 5.3 M (+34.50 %) |
| Dec 13 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Buy | C | 0.00 | 3,952,719 | 0 | 3,952,719 | 0 to 4 M |
| Dec 07 2018 | THOR | Synthorx, Inc. | Thompson Peter A. | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 |
Page: 1